Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 11,945,583 PYXS shares, 9.99% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:20:52 UTC.

Accession
0000921895-26-003186
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
11,945,583
Percent of class
9.99%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN06,250,28006,250,2806,250,2805.2%
BVF I GP LLCOO06,250,28006,250,2806,250,2805.2%
BIOTECHNOLOGY VALUE FUND II LPPN04,609,21704,609,2174,609,2173.9%
BVF II GP LLCOO04,609,21704,609,2174,609,2173.9%
Biotechnology Value Trading Fund OS LPPN0844,1160844,116844,1160.7%
BVF Partners OS Ltd.CO0844,1160844,116844,1160.7%
BVF GP HOLDINGS LLCOO010,859,497010,859,49710,859,4979.1%
BVF PARTNERS L P/ILIA,PN011,945,583011,945,58311,945,5839.99%
BVF INC/ILCO011,945,583011,945,58311,945,5839.99%
LAMPERT MARK NIN011,945,583011,945,58311,945,5839.99%